Kaitlyn D’Onofrio

DocwireNews

A new report issued by the <a href="https://www.cdc.gov/mmwr/volumes/69/ss/ss6901a1.htm?s_cid=ss6901a1_w">Centers for Disease Control and Prevention (CDC)</a> observed a decline in opioid prescriptions across almost a dozen states.Drug overdoses claimed the lives of more than 70,000 persons in the U.S. in 2017, according to the analysis; a third of these deaths were related to opioids. A historical trend has been observed between the <a href="https://www.docwirenews.com/future-of-medicine/trump-signs-legislation-aiming-to-take-on-opioid-crisis/">opioid epidemic</a> and an increase in <a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/suicide-attempts-with-non-opioid-medications-on-the-rise/">opioid</a> prescriptions.&ldquo;Various factors contributed to the increase in opioid prescribing, including changing attitudes toward the role of opioids in <a href="https://www.docwirenews.com/docwire-pick/addressing-pain-management-consulting/">chronic pain management</a>, calls for more liberal use of opioids by professional pain management societies, and state regulations that have encouraged the use of opioids for chronic pain management,&rdquo; the report explains.When broken down by specialty, <a href="https://www.ncbi.nlm.nih.gov/pubmed/30875645">orthopedic surgeons prescribe</a> about 11% of opioids, even though there are only about <a href="https://blog.definitivehc.com/how-many-orthopedic-surgeons-in-us">30,500 orthopedic surgeons</a> among more than 1 million doctors in the U.S.; this is largely because orthopedic surgeons perform significantly painful procedures.The data for the analysis were obtained from the Prescription Behavior Surveillance System (PBSS). PBSS was formed in 2011 and is a collaborative effort between the Bureau of Justice Assistance, CDC&rsquo;s Unintentional Injury Center, Food and Drug Administration&rsquo;s Safe Use Initiative, and Prescription Drug Monitoring Program Training and Technical Assistance Center at Brandeis University. The goal of the PBSS was to &ldquo;track rates of prescribing of controlled substances and possible misuse of such drugs using data from selected state prescription drug monitoring programs (PDMP),&rdquo; according to the CDC. Data calculated using PDMP data include:<ul>
<li>Opioid prescribing</li>
<li>Average daily opioid dosage</li>
<li>Proportion of patients with daily opioid dosages &ge;90 morphine milligram equivalents</li>
<li>Overlapping opioid prescriptions</li>
<li>Overlapping opioid and benzodiazepine prescriptions</li>
<li>Multiple-provider episodes</li>
</ul>The analysis included PBSS data spanning 2010&ndash;2016 encompassing 11 states, representing about 38.0% of the national population. State calculations were performed for average quarterly percent changes (AQPC) in the rates of opioid prescribing as well as possible misuse.<h2>Opioid Prescriptions Declining Across the Board</h2>In all 11 states evaluated during the study period, opioid prescribing rates declined (range, 14.9&ndash;33.0%). The lowest daily dosage declines were observed in Idaho and Maine (AQPC=-0.4%), and the highest in Florida (AQPC=-1.6%). AQPCs for the percentage of patients with high daily dosage ranged from -0.4% in Idaho to -2.3% in Louisiana. For the seven states where multiple-provider episode data were available, rates declined by at least 62%.The analysts concluded, &ldquo;PDMP data collected by PBSS indicate that steady progress is being made in reducing the use and possible misuse of prescription-controlled substances in the United States. However, some persons who were misusing prescription opioids might have transitioned to heroin or illicitly manufactured fentanyl, a change that has made the drug overdose epidemic and associated overdose rates more complex. Because the opioid overdose epidemic began with increased deaths and treatment admissions related to opioid analgesics in the late 1990s, initiatives to address overprescribing might eventually result in fewer persons misusing either prescription or illicit drugs.&rdquo;

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Opioid Prescriptions Are On the Decline in the United States, According to CDC Report

Orthopedics

A new report issued by the Centers for Disease Control and Prevention (CDC) observed a decline in opioid prescriptions across almost a dozen states. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe